Full Text View
Tabular View
No Study Results Posted
Related Studies
General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment
This study has been completed.
First Received: April 20, 2006   Last Updated: April 15, 2008   History of Changes
Sponsored by: Boehringer Ingelheim Pharmaceuticals
Information provided by: Boehringer Ingelheim Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00319813
  Purpose

A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment


Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive
Behavioral: Education
Phase IV

MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease)
U.S. FDA Resources
Study Type: Observational
Official Title: General Practice Quality Assurance Project. COPD Diagnosis and Treatment

Further study details as provided by Boehringer Ingelheim Pharmaceuticals:

Primary Outcome Measures:
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment amongst PCPs
  • To focus on implementation of national guidelines for diagnosis and treatment of COPD

Estimated Enrollment: 8000
Estimated Study Completion Date: September 2007
  Eligibility

Ages Eligible for Study:   35 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD patients over 35 years of age
  • More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these

Exclusion Criteria:

  • Asthma
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00319813

Sponsors and Collaborators
Boehringer Ingelheim Pharmaceuticals
Investigators
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
  More Information

No publications provided

Study ID Numbers: 205.376
Study First Received: April 20, 2006
Last Updated: April 15, 2008
ClinicalTrials.gov Identifier: NCT00319813     History of Changes
Health Authority: Denmark: Danish Dataprotection Agency

Study placed in the following topic categories:
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Respiration Disorders
Chronic Disease
Pulmonary Disease, Chronic Obstructive

Additional relevant MeSH terms:
Disease Attributes
Lung Diseases, Obstructive
Pathologic Processes
Respiratory Tract Diseases
Lung Diseases
Respiration Disorders
Chronic Disease
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on May 06, 2009